NCODA IMMUNOTHERAPY RESOURCES
Harnessing the immune system, implemented with confidence.
Practice-ready tools for the oncology care team delivering T-cell–redirecting therapies. Choose a hub below to explore curated clinical education, patient resources, and real-world implementation support.
T-CELL
TUMOR CELL
HUB 01
Bispecific T-Cell Engager Hub
Support the safe, effective implementation of bispecific T-cell engager (BTCE) therapies across a range of clinical settings — from step-up dosing to CRS and ICANS management.
-
Clinical education & microlearning videos
-
Treatment discussion guides & PQIs
-
Patient education sheets & treatment calendars
-
EMR toolkits & implementation resources
HUB 02
CAR-T Cell Therapy Hub
Curated, practice-ready resources supporting the safe, effective implementation of CAR-T cell therapy — across every stage of the patient journey, from referral and apheresis to infusion and monitoring.
-
Foundations clinical education
-
“Up Close” agent-specific resources for FDA-approved CAR-T therapies
-
Example SOPs & real-world practice documents
-
Implementation toolkits & recommended reading
Bispecific T-Cell Engager Hub
CAR-T Cell Therapy Hub
NOW LIVE
COMING SOON
AT A GLANCE
Two approaches. One goal.
Both therapy classes redirect a patient’s T cells against cancer — but they differ in how they’re made, delivered, and managed.
BISPECIFIC T-CELL ENGAGERS
CAR-T CELL THERAPY
How it works
An antibody that binds a T cell and a tumor-cell target at the same time, bringing them together.
The patient’s own T cells are genetically engineered to express a chimeric antigen receptor that recognizes the tumor.
Product
Off-the-shelf; available without cell manufacturing.
Personalized; requires apheresis and a manufacturing period.
Administration
Repeated dosing, typically starting with a step-up schedule.
Typically a single infusion following lymphodepleting chemotherapy.
Key safety focus
CRS and ICANS, most often during step-up dosing; infection risk.
CRS and ICANS after infusion; prolonged monitoring and infection risk.
Care setting
Hospital and increasingly community practice settings.
Certified treatment centers with coordinated referral pathways.
General educational overview. Refer to each product’s prescribing information and institutional protocols.
INSIDE THE HUBS
Built for every member of the care team
Resources developed with oncology practitioners to move immunotherapy from guideline to real-world practice.
Clinical Education
Microlearning videos, podcasts, and foundational overviews.
Patient Resources
Education sheets and treatment calendars to support the patient journey.
SOPs & Toolkits
Example SOPs, EMR toolkits, and workflow documents from real practices.
Discussion Guides
Treatment discussion guides and PQIs for pharmacists, nurses, and prescribers.
Advancing immunotherapy, together.
Start with the hub that fits your practice today — and check back as NCODA continues to expand its immunotherapy resources.
→
→